As of November 7, 2026, Biovie Inc. is a publicly traded company (Nasdaq: BIVI). The largest holder reporting an active stake on Schedule 13D is Cuong Do V, the chief executive and president, at 5.03%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include Morgan Stanley (11.9%), Alta Partners LLC (8.4%) (Schedule 13D, March 25, 2026).
Is this your company?
About to sign with, pay or invest in Biovie Inc.? See the free Snapshot first.
Free to see. No signup.
Is Biovie Inc. a real, registered company?
- Biovie Inc. files with the SEC under CIK 1580149 (its SEC filings).
- Its shares are listed under the ticker BIVI on Nasdaq (also BIVIW) (SEC company record).
- Incorporated in Nevada; business address in Carson City, Nevada, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under BIOVIE INC. in our court records and SEC 8-K records (as of 2026-11-07).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Jane Street (filed 2026-09-03).
Who are Biovie Inc.'s owners and officers?
Biovie Inc.: incorporated in Nevada; business address in Carson City, Nevada; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-11-06).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-11-06 | Jane Street Group, LLC | 2.7% |
| Schedule 13G, 2026-09-03 | Jane Street Group, LLC | 5.2% |
| Schedule 13G, 2026-08-19 | Alta Partners LLC | 8.4% |
| Schedule 13G/A, 2026-08-07 | Morgan Stanley | 11.9% |
| Schedule 13G, 2026-08-07 | Morgan Stanley | 8% |
| Schedule 13D, 2026-03-25 | Do Cuong V | 5.03% |
Questions about who owns Biovie Inc.
Who owns Biovie Inc.?
On this page, 3 holders' latest ownership filings report 5% or more of Biovie Inc.: Morgan Stanley (11.9%, Schedule 13G/A, filed 2026-08-07), Alta Partners LLC (8.4%, Schedule 13G, filed 2026-08-19) and Do Cuong V (5.03%, Schedule 13D, filed 2026-03-25).
Who are the largest shareholders of Biovie Inc.?
By the share each holder's latest filing reports, the largest holders of Biovie Inc. on this page are Morgan Stanley (11.9%), Alta Partners LLC (8.4%) and Do Cuong V (5.03%).
When did Morgan Stanley buy into Biovie Inc.?
The filings give report dates, not purchase dates. The earliest filing from Morgan Stanley on this page is the Schedule 13G/A, filed 2026-08-07, reporting 11.9%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 6 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Biovie Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Biovie Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Biovie Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
17 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Biovie Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director: 40,643 shares (0.38% of shares outstanding) (Form 4, 2025-01-07).
- , a director: 36,926 shares (0.34% of shares outstanding) (Form 4, 2025-01-07).
- , the chief executive and president: 16,117 shares (0.15% of shares outstanding) (Form 4, 2026-08-28).
- , the chief medical officer: 6,036 shares (0.06% of shares outstanding) (Form 4, 2026-08-28).
- , the chief financial officer: 3,441 shares (0.03% of shares outstanding) (Form 4, 2026-08-28).
Shares outstanding: 10,724,724 as of 2026-11-05, from the company's latest SEC cover page.
How much has Biovie Inc. raised?
Latest IPO step: Biovie Inc. amended its IPO registration (S-1/A, 2026-08-14).
IPO filings: S-1/A, 2026-08-14, S-1/A, 2026-08-06, S-1/A, 2026-07-31, S-1, 2026-07-17, S-1/A, 2025-08-04; ticker BIVI on Nasdaq.
Keep reading
More on Biovie Inc. and the records around it.
Biovie Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
Companies that share a holder
- Alta Partners LLC also filed stake reports on 26 other companies: Robin Energy Ltd. (Oct 2026), Huachen AI Parking Management Technology Holding Co., Ltd (Oct 2026), C3is Inc. (Oct 2026)
- JANE STREET GROUP, LLC also filed stake reports on 73 other companies: AXT INC (Nov 2026), Bitdeer Technologies Group (Nov 2026), Bloom Energy Corp (Nov 2026)
- Morgan Stanley also filed stake reports on 182 other companies: MDA Space Ltd. (Nov 2026), RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. (Oct 2026), Arbutus Biopharma Corp (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/biovie